PUR Biologics (OTCMKTS:ORHB) Stock In Focus After Recent Launch of PURfiberXP
As the trading week comes to a close, it may be a good time for investors to consider keeping an eye on the HippoFi Inc stock. Yesterday, the company’s fully owned subsidiary unit PUR Biologics (OTCMKTS:ORHB) was in focus after it announced that it had released a new product named PURfiberXP.
Trading Data
On Thursday, ORHB stock lost 1.62% to $0.0787 with more than 5.76K shares, compared to volume of 23.84K shares. The stock moved within a range of $0.0747 – 0.0845 after opening trade at $0.0770.
PUR Biologics Launches PURfiberXP™, a Best-in-Class Cortical Fiber Matrix for Bone Regeneration
The product in question was processed uniquely and is a demineralized extracellular matrix that would help with bone regeneration, patient healing and cellular integration. In light of that announcement, it will be interesting to see if the HippoFi stock gets any attention from investors this morning or not.
The product is a specialized biologic that had been derived from cortical bone fibres with the deployment of a proprietary process. The advanced surface of the product provides a completely interconnected matrix and helps with cell migration.
It was also noted in the press release yesterday that the worldwide bone regeneration market is projected to grow at a significant rate in the coming year and PURfiberXP may have been launched at just the right time. The growth is expected to be driven by the fact that the global population would be ageing rapidly and there would be rising demand for bone regeneration.
